Author

S. J. Carmona

University of Lausanne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 5 Organism:mouse· 5 Research Focus:differential expression· 4 Approach:deep learning· 3 Approach:experimental assay· 3 Organism:human· 3 Approach:statistical model· 3 Research Focus:cell signaling & trafficking· 2

Frequent Co-Authors

M. Andreatta· 2 shared W. Held· 2 shared A. D. Ricci· 1 shared A. Spill· 1 shared A. Tjitropranoto· 1 shared B. Seijo· 1 shared C. Jimenez-Luna· 1 shared C. Lopez-Rodriguez· 1 shared

Activity by Year

2019-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Andreatta

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Wounding triggers invasive progression in human basal cell carcinoma

Laura Yerly, Massimo Andreatta, J. Garnica, Charles Nardin, J. Di Domizio, François Aubin, M. Gilliet, S. J. Carmona, François Kuonen

This study shows that wounding, such as biopsy, triggers invasive progression in human basal cell carcinoma by activating a wound response gene program and reprogramming cancer-associated fibroblasts.

Journal of Investigative Dermatology · Jul 21, 2025Peer-reviewedCancer Biology

NFAT5 induction by the tumor microenvironment enforces CD8 T cell exhaustion

L. Tille, D. Cropp, G. Bodley, M. Andreatta, M. Charmoy, I. Crespo-Casajus, S. Nassiri, J. Lourenco, M. M. Leblond, C. Lopez-Rodriguez, D. E. Speiser, S. J. Carmona, W. Held, G. Verdeil

This study identifies NFAT5 as a key driver of CD8 T cell exhaustion in the tumor microenvironment, showing its role in reducing tumor control and its absence improving it.

bioRxiv · Mar 15, 2022Immunology

Orthogonal Gene Engineering Enables CD8+ T Cells to Control Tumors through a Novel PD-1+ TOX-indifferent Synthetic Effector State

J. Corria-Osorio, S. J. Carmona, E. Stefanidis, M. J. Andreatta, T. Muller, Y. Ortiz, B. Seijo, W. Castro, C. Jimenez-Luna, L. Scarpellino, C. Ronet, A. Spill, E. Lanitis, S. A. Luther, P. Romero, , G. Coukos

This study shows that orthogonal gene engineering of CD8+ T cells with IL-2 variant, PD1-decoy, and IL-33 enables tumor control through a novel PD-1+ TOX-indifferent synthetic effector state.

bioRxiv · Feb 18, 2022 · PreprintImmunology

A single-cell reference atlas delineates CD4+ T cell subtype-specific adaptation during acute and chronic viral infections

M. Andreatta, Z. Sherman, A. Tjitropranoto, M. C. Kelly, T. Ciucci, S. J. Carmona

This study constructs a single-cell reference atlas of CD4+ T cell states during acute and chronic viral infections, identifying six distinct transcriptional states and their dynamics.

bioRxiv · Sep 20, 2021Immunology

APRANK: computational prioritization of antigenic proteins and peptides from complete pathogen proteomes

A. D. Ricci, M. Brunner, D. Ramoa, S. J. Carmona, M. Nielsen, F. Aguero

APRANK prioritizes antigenic proteins and peptides from pathogen proteomes using molecular features, successfully predicting antigenicity across multiple disease-causing organisms.

bioRxiv · Apr 27, 2021Immunology

Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq

S. J. Carmona, I. Siddiqui, M. Bilous, W. Held, D. Gfeller

This study identifies four CD8 TIL states in B16 melanoma tumors using single-cell RNA-seq and finds anti-PD-1 treatment expands EM-like cells.

bioRxiv · Oct 10, 2019Immunology